back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-02 17:29 Tx date 2024-03-29 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,264 vol |
19,038 | |
| Filed 2024-04-01 17:30 Tx date 2024-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+5,890 vol |
208,309 | |
| Filed 2024-01-03 21:42 Tx date 2023-12-29 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,282 vol |
17,774 | |
| Filed 2024-01-02 17:18 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+7,793 vol $8.02 each |
202,419 | |
| Filed 2023-10-03 21:08 Tx date 2023-09-29 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,290 vol |
16,492 | |
| Filed 2023-10-03 11:45 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,496
+7,603 vol $8.22 each |
194,626 | |
| Filed 2023-07-05 16:16 Tx date 2023-06-30 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,089 vol |
15,202 | |
| Filed 2023-07-04 16:49 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,496
+7,812 vol $8.00 each |
187,023 | |
| Filed 2023-05-23 12:53 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
179,211 | |
| Filed 2023-05-08 09:56 Tx date 2023-05-04 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,857 vol |
14,113 | |
| Filed 2023-04-27 16:46 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$214,000
+12,500 vol $17.12 each |
12,500 | |
| Filed 2023-04-27 16:46 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-27 16:45 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-214,000
-12,500 vol $17.12 each |
1,256 | |
| Filed 2023-04-05 12:38 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+7,716 vol $8.10 each |
150,006 | |
| Filed 2023-04-04 17:12 Tx date 2023-03-31 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,256 vol |
13,756 | |
| Filed 2023-01-04 17:03 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,498
+9,952 vol $6.28 each |
142,290 | |
| Filed 2022-10-04 16:36 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+9,071 vol $6.89 each |
132,338 | |
| Filed 2022-07-06 15:02 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$18,818
+2,251 vol $8.36 each |
123,267 | |
| Filed 2022-06-29 13:05 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
121,016 | |
| Filed 2022-06-29 13:02 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
||
| Filed 2022-05-12 09:19 Tx date 2022-05-10 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,500 vol |
12,500 | |
| Filed 2022-05-12 09:19 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-05 11:55 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+1,340 vol $22.85 each |
86,629 | |
| Filed 2022-01-04 12:55 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,109 vol |
85,289 | |
| Filed 2021-10-04 18:22 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,607
+1,099 vol $27.85 each |
84,180 | |
| Filed 2021-07-05 11:25 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,610
+1,044 vol $29.32 each |
83,081 | |
| Filed 2021-05-03 19:50 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
82,037 | |
| Filed 2021-04-05 13:09 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,216
+952 vol $31.74 each |
74,392 | |
| Filed 2021-01-07 12:12 Tx date 2020-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,993
+1,442 vol $20.80 each |
73,440 | |
| Filed 2020-10-05 13:03 Tx date 2020-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,992
+1,930 vol $15.54 each |
71,998 | |
| Filed 2020-07-03 11:37 Tx date 2020-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$28,258
+1,545 vol $18.29 each |
70,068 | |
| Filed 2020-05-15 18:18 Tx date 2020-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,314,792
+585,100 vol $15.92 each |
12,215,361 | |
| Filed 2020-05-15 18:18 Tx date 2020-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,917,163
+624,900 vol $15.87 each |
11,630,261 | |
| Filed 2020-05-15 18:17 Tx date 2020-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,095,500
+70,000 vol $15.65 each |
11,005,361 | |
| Filed 2020-05-15 18:16 Tx date 2020-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,530,382
+348,920 vol $15.85 each |
10,935,361 | |
| Filed 2020-05-15 18:15 Tx date 2020-05-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,785,594
+645,844 vol $16.70 each |
10,586,441 | |
| Filed 2020-05-15 18:14 Tx date 2020-05-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,331,373
+80,300 vol $16.58 each |
9,940,597 | |
| Filed 2020-05-15 18:14 Tx date 2020-05-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,855,648
+603,900 vol $16.32 each |
9,860,297 | |
| Filed 2020-05-15 18:13 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,495,907
+374,836 vol $17.33 each |
9,256,397 | |
| Filed 2020-05-15 18:12 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,850,750
+162,900 vol $17.50 each |
8,881,561 | |
| Filed 2020-05-15 18:12 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,790,275
+799,900 vol $17.24 each |
8,718,661 | |
| Filed 2020-05-15 18:11 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$432,500
+25,000 vol $17.30 each |
7,918,761 | |
| Filed 2020-05-15 18:10 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,851,648
+678,400 vol $17.47 each |
7,893,761 | |
| Filed 2020-05-04 11:01 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
68,523 | |
| Filed 2020-04-02 17:51 Tx date 2020-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,497
+1,774 vol $15.50 each |
57,486 | |
| Filed 2020-01-03 12:20 Tx date 2019-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,496
+919 vol $29.92 each |
55,712 | |
| Filed 2019-10-04 17:18 Tx date 2019-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,487
+1,258 vol $21.85 each |
54,793 | |
| Filed 2019-07-05 16:12 Tx date 2019-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,489
+1,090 vol $25.22 each |
53,535 | |
| Filed 2019-05-06 11:38 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
52,445 | |
| Filed 2019-04-12 10:24 Tx date 2019-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,113 vol |
41,812 | |
| Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$9,236,000 vol $96.88 each |
$18,471,040 | |
| Filed 2019-03-18 Tx date 2019-03-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$840,960 vol $97.00 each |
$306,000 | |
| Filed 2019-03-18 Tx date 2019-03-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$306,000 vol $96.75 each |
$0 | |
| Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$382,000 vol $97.13 each |
$1,146,960 | |
| Filed 2019-03-18 Tx date 2019-03-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$764,000 vol $96.50 each |
$2,292,960 | |
| Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$4,618,000 vol $97.13 each |
||
| Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$764,000 vol $96.88 each |
$1,528,960 | |
| Filed 2019-03-18 Tx date 2019-03-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$3,694,000 vol $96.75 each |
$0 | |
| Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$4,618,000 vol $97.13 each |
||
| Filed 2019-03-18 Tx date 2019-03-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$10,159,040 vol $97.00 each |
$3,694,000 | |
| Filed 2019-03-18 Tx date 2019-03-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$9,236,000 vol $96.50 each |
$27,707,040 | |
| Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$4,618,000 vol $97.13 each |
$13,853,040 | |
| Filed 2019-03-11 Tx date 2019-03-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$1,826,000 vol $95.50 each |
||
| Filed 2019-03-11 Tx date 2019-03-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$1,826,000 vol $95.50 each |
||
| Filed 2019-03-11 Tx date 2019-03-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$456,000 vol $96.13 each |
$7,164,960 | |
| Filed 2019-03-11 Tx date 2017-06-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-11 Tx date 2019-03-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$22,718,000 vol $96.00 each |
$55,117,040 | |
| Filed 2019-03-11 Tx date 2019-03-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$4,544,000 vol $96.13 each |
$77,835,040 | |
| Filed 2019-03-11 Tx date 2019-03-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$18,174,000 vol $95.50 each |
$36,943,040 | |
| Filed 2019-03-11 Tx date 2019-03-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$1,826,000 vol $95.50 each |
$3,056,960 | |
| Filed 2019-03-11 Tx date 2018-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
90 - Change in the nature of ownership
|
-$7,620,960 vol |
$82,379,040 | |
| Filed 2019-03-11 Tx date 2019-03-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$2,282,000 vol $96.00 each |
$4,882,960 | |
| Filed 2019-03-11 Tx date 2018-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
90 - Change in the nature of ownership
|
+$7,620,960 vol |
$7,620,960 | |
| Filed 2019-01-07 Tx date 2018-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,483
+1,488 vol $18.47 each |
40,699 | |
| Filed 2018-10-03 Tx date 2018-09-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,071 vol |
39,211 | |
| Filed 2018-07-06 Tx date 2018-06-29 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,492
+1,183 vol $23.24 each |
38,140 | |
| Filed 2018-05-10 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+13,881 vol |
36,957 | |
| Filed 2018-05-10 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
||
| Filed 2018-05-04 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
37,361 | |
| Filed 2018-04-06 Tx date 2018-03-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,493
+1,727 vol $15.92 each |
23,076 | |
| Filed 2018-03-29 Tx date 2018-03-26 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 5.375% 03/15/2020
38 - Redemption, retraction, cancellation, repurchase
|
$
-$75,000,000 vol $1,013 each |
$0 | |
| Filed 2018-03-09 Tx date 2018-03-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$108,826,086
+7,066,629 vol $15.40 each |
7,215,361 | |
| Filed 2018-03-09 Tx date 2018-03-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners Enhanced LP (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-16,917,978
-1,098,570 vol $15.40 each |
405,317 | |
| Filed 2018-03-09 Tx date 2018-03-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson International Ltd (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-28,349,844.60
-1,840,899 vol $15.40 each |
1,211,761 | |
| Filed 2018-03-09 Tx date 2018-03-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Enhanced Ltd (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-63,558,264
-4,127,160 vol $15.40 each |
2,961,296 | |
| Filed 2018-01-03 Tx date 2017-09-29 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$26,653
+1,860 vol $14.33 each |
20,026 | |
| Filed 2018-01-03 Tx date 2017-12-29 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,491
+1,323 vol $20.78 each |
21,349 | |
| Filed 2018-01-03 Tx date 2017-06-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$4,653
+269 vol $17.30 each |
18,166 | |
| Filed 2017-11-21 Tx date 2017-11-16 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Separately Managed Account (Control or Direction)
|
Equity Swap - Long Position
70 - Acquisition or disposition (writing) of third party derivative
|
$-3,726,030.75
-259,500 vol $14.36 each |
0 | |
| Filed 2017-11-21 Tx date 2017-11-16 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-159,757.7361
-11,103 vol $14.39 each |
148,732 | |
| Filed 2017-11-21 Tx date 2017-11-16 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners Enhanced LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,793,063.0231
-333,113 vol $14.39 each |
1,503,887 | |
| Filed 2017-11-21 Tx date 2017-11-16 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson International Ltd (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,540,963
+245,960 vol $14.40 each |
3,052,660 | |
| Filed 2017-11-21 Tx date 2017-11-16 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Enhanced Ltd (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,414,542
+98,256 vol $14.40 each |
7,088,456 | |
| Filed 2017-08-11 Tx date 2017-08-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$13,000,000 vol $84.92 each |
$90,000,000 | |
| Filed 2017-08-11 Tx date 2017-08-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$37,000,000 vol $84.00 each |
$103,000,000 | |
| Filed 2017-08-11 Tx date 2017-08-11 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 5.875% 05/15/2023
10 - Acquisition or disposition in the public market
|
$
-$8,000,000 vol $84.50 each |
$0 | |
| Filed 2017-08-11 Tx date 2017-08-11 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 5.875% 05/15/2023
10 - Acquisition or disposition in the public market
|
$
-$8,000,000 vol $84.50 each |
||
| Filed 2017-08-11 Tx date 2017-08-10 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 5.875% 05/15/2023
10 - Acquisition or disposition in the public market
|
$
-$2,000,000 vol $84.63 each |
$8,000,000 | |
| Filed 2017-08-09 Tx date 2017-08-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Separately Managed Account (Indirect Ownership)
|
Equity Swap - Long Position
70 - Acquisition or disposition (writing) of third party derivative
|
$-8,806,573.80
-603,000 vol $14.60 each |
259,500 | |
| Filed 2017-08-09 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Separately Managed Account (Control or Direction)
|
Equity Swap - Long Position
00 - Opening Balance-Initial SEDI Report
|
862,500 | ||
| Filed 2017-08-09 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Separately Managed Account (Control or Direction)
|
Equity Swap - Long Position
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-09 Tx date 2017-08-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners Premium LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-362,089.65
-24,700 vol $14.66 each |
0 | |
| Filed 2017-08-09 Tx date 2017-08-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,482,939.5675
-578,665 vol $14.66 each |
159,835 | |
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
17,897 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Separately Managed Account (Control or Direction)
|
Equity Swap - Long Position
00 - Opening Balance-Initial SEDI Report
|
1 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: UTMA Account 3 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: UTMA Account 2 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: UTMA Account 1 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: UTMA Account 4 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
30 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: UTMA Account 3 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
35 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: UTMA Account 2 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
30 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: UTMA Account 1 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
125 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Recovery Master Fund (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,500,000 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners Premium LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
24,700 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
738,500 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners Enhanced LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,837,000 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson International Ltd (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,806,700 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Enhanced Ltd (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,990,200 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Advantage Plus Master Ltd (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,836,200 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Advantage Master Ltd (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,709,100 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Control or Direction)
|
Bonds Corporate Bond 6.125% 04/15/2025
00 - Opening Balance-Initial SEDI Report
|
$140,000,000 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Control or Direction)
|
Bonds Corporate Bond 5.875% 05/15/2023
00 - Opening Balance-Initial SEDI Report
|
$10,000,000 | ||
| Filed 2017-06-26 Tx date 2017-06-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Control or Direction)
|
Bonds Corporate Bond 5.375% 03/15/2020
00 - Opening Balance-Initial SEDI Report
|
$75,000,000 |